Skip to main content
Erschienen in: Familial Cancer 4/2018

27.02.2018 | Original Article

Urological sequelae of desmoids associated with familial adenomatous polyposis

verfasst von: S. J. Walton, G. Malietzis, S. K. Clark, E. Havranek

Erschienen in: Familial Cancer | Ausgabe 4/2018

Einloggen, um Zugang zu erhalten

Abstract

The aim of this retrospective cohort study was to review urological complication rates arising from familial adenomatous polyposis associated desmoid tumours and their management. All patients over a 35-year period were identified from a prospectively maintained polyposis registry database and had an intra-abdominal desmoid tumour. Those without ureteric complications (n = 118, group A) were compared to those that developed ureteric obstruction (n = 40, group B) for demographics, treatment interventions and survival outcomes. 158 (56% female) patients were identified. Median age at diagnosis was 31 years and desmoids typically occurred 3.6 years after colectomy for familial adenomatous polyposis. Ureteric obstruction secondary to tumour growth occurred in 25% of cases. There was no significant difference in gender distribution or overall age at desmoid diagnosis between the two groups. In group B, the median age at desmoid diagnosis was significantly younger in women compared to men (25 and 43 years, respectively) (p = 0.01). Thirty-eight percent of patients already had ureteric obstruction at desmoid diagnosis, the remainder occurred after 48.6 months, but 20 years in two cases. Seventy-three percent (29/40) had ureteric stenting, a long-term requirement for most. Permanent renal injury occurred in six cases but survival between the two groups was not significantly different. Ureteric obstruction occurs frequently in patients with familial adenomatous polyposis and an intra-abdominal desmoid tumour. Those most at risk are the young following colectomy. Clinicians should actively survey the renal tract at regular intervals after a diagnosis of an intra-abdominal desmoid tumour as complications can arise insidiously, at any stage.
Literatur
1.
Zurück zum Zitat Reitamo JJ, Hayry P, Nykyri E, Saxen E (1982). The desmoid tumor. I. Incidence, sex-, age- and anatomical distribution in the Finnish population. Am J Clin Pathol 77:665–673CrossRef Reitamo JJ, Hayry P, Nykyri E, Saxen E (1982). The desmoid tumor. I. Incidence, sex-, age- and anatomical distribution in the Finnish population. Am J Clin Pathol 77:665–673CrossRef
2.
Zurück zum Zitat Caspari R, Olschwang S, Friedl W, Mandl M, Boisson C, Böker T, Augustin A, Kadmon M, Möslein G, Thomas G et al (1995) Familial adenomatous polyposis: desmoid tumours and lack of ophthalmic lesions (CHRPE) associated with APC mutations beyond codon 1444. Hum Mol Genet 4:337–340CrossRef Caspari R, Olschwang S, Friedl W, Mandl M, Boisson C, Böker T, Augustin A, Kadmon M, Möslein G, Thomas G et al (1995) Familial adenomatous polyposis: desmoid tumours and lack of ophthalmic lesions (CHRPE) associated with APC mutations beyond codon 1444. Hum Mol Genet 4:337–340CrossRef
3.
Zurück zum Zitat Miyoshi Y, Iwao K, Nawa G, Yoshikawa H, Ochi T, Nakamura Y (1998) Frequent mutations in the beta-catenin gene in desmoid tumors from patients without familial adenomatous polyposis. Oncol Res 10:591–594PubMed Miyoshi Y, Iwao K, Nawa G, Yoshikawa H, Ochi T, Nakamura Y (1998) Frequent mutations in the beta-catenin gene in desmoid tumors from patients without familial adenomatous polyposis. Oncol Res 10:591–594PubMed
4.
Zurück zum Zitat Huss S, Nehles J, Binot E, Wardelmann E, Mittler J, Kleine MA et al (2013) Beta-catenin (CTNNB1) mutations and clinicopathological features of mesenteric desmoid-type fibromatosis. Histopathology 62:294–304CrossRef Huss S, Nehles J, Binot E, Wardelmann E, Mittler J, Kleine MA et al (2013) Beta-catenin (CTNNB1) mutations and clinicopathological features of mesenteric desmoid-type fibromatosis. Histopathology 62:294–304CrossRef
5.
Zurück zum Zitat Petersen GM, Slack J, Nakamura Y (1991) Screening guidelines and premorbid diagnosis of familial adenomatous polyposis using linkage. Gastroenterology 100:1658–1664CrossRef Petersen GM, Slack J, Nakamura Y (1991) Screening guidelines and premorbid diagnosis of familial adenomatous polyposis using linkage. Gastroenterology 100:1658–1664CrossRef
6.
Zurück zum Zitat Sturt NJ, Clark SK (2006). Current ideas in desmoid tumours. Fam Cancer 5:275–285 (discussion 87–8)CrossRef Sturt NJ, Clark SK (2006). Current ideas in desmoid tumours. Fam Cancer 5:275–285 (discussion 87–8)CrossRef
7.
Zurück zum Zitat Vasen HF, Moslein G, Alonso A, Aretz S, Bernstein I, Bertario L et al (2008) Guidelines for the clinical management of familial adenomatous polyposis (FAP). Gut 57:704–713CrossRef Vasen HF, Moslein G, Alonso A, Aretz S, Bernstein I, Bertario L et al (2008) Guidelines for the clinical management of familial adenomatous polyposis (FAP). Gut 57:704–713CrossRef
8.
Zurück zum Zitat Nieuwenhuis MH, Lefevre JH, Bulow S, Järvinen H, Bertario L, Kernéis S, Parc Y, Vasen HF et al (2011) Family history, surgery, and APC mutation are risk factors for desmoid tumors in familial adenomatous polyposis: an international cohort study. Dis Colon Rectum 54:1229–1234CrossRef Nieuwenhuis MH, Lefevre JH, Bulow S, Järvinen H, Bertario L, Kernéis S, Parc Y, Vasen HF et al (2011) Family history, surgery, and APC mutation are risk factors for desmoid tumors in familial adenomatous polyposis: an international cohort study. Dis Colon Rectum 54:1229–1234CrossRef
9.
Zurück zum Zitat Sinha A, Tekkis PP, Gibbons DC, Phillips RK, Clark SK (2011) Risk factors predicting desmoid occurrence in patients with familial adenomatous polyposis: a meta-analysis. Colorectal Dis 13:1222–1229CrossRef Sinha A, Tekkis PP, Gibbons DC, Phillips RK, Clark SK (2011) Risk factors predicting desmoid occurrence in patients with familial adenomatous polyposis: a meta-analysis. Colorectal Dis 13:1222–1229CrossRef
10.
Zurück zum Zitat Schlemmer M (2005) Desmoid tumors and deep fibromatoses. Hematol Oncol Clin North America 19:565–571CrossRef Schlemmer M (2005) Desmoid tumors and deep fibromatoses. Hematol Oncol Clin North America 19:565–571CrossRef
11.
Zurück zum Zitat Joyce M, Mignanelli E, Church J (2010) Ureteric obstruction in familial adenomatous polyposis-associated desmoid disease. Dis Colon Rectum 53:327–332CrossRef Joyce M, Mignanelli E, Church J (2010) Ureteric obstruction in familial adenomatous polyposis-associated desmoid disease. Dis Colon Rectum 53:327–332CrossRef
12.
Zurück zum Zitat Church J, Xhaja X, LaGuardia L, O’Malley M, Burke C, Kalady M (2015) Desmoids and genotype in familial adenomatous polyposis. Dis Colon Rectum 58:444–448CrossRef Church J, Xhaja X, LaGuardia L, O’Malley M, Burke C, Kalady M (2015) Desmoids and genotype in familial adenomatous polyposis. Dis Colon Rectum 58:444–448CrossRef
Metadaten
Titel
Urological sequelae of desmoids associated with familial adenomatous polyposis
verfasst von
S. J. Walton
G. Malietzis
S. K. Clark
E. Havranek
Publikationsdatum
27.02.2018
Verlag
Springer Netherlands
Erschienen in
Familial Cancer / Ausgabe 4/2018
Print ISSN: 1389-9600
Elektronische ISSN: 1573-7292
DOI
https://doi.org/10.1007/s10689-017-0064-0

Weitere Artikel der Ausgabe 4/2018

Familial Cancer 4/2018 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.